Drugs / Implitapide
Implitapide
Trials 3
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT00080132 | Oct 2004 → Apr 2005 | hypertriglyceridemia | Medical Research Laboratories International | Terminated | No outcome recorded |
| Phase 2 | NCT00079859 | Oct 2003 → Apr 2005 | familial hypercholesterolemia | Medical Research Laboratories International | Terminated | No outcome recorded |
| Phase 2 | NCT00079846 | Sep 2003 → Apr 2005 | familial hypercholesterolemia | Medical Research Laboratories International | Terminated | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 4 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Implitapide | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00079846 ↗ |
| Known as | BAY-13-9952 | ChEMBL registry synonym — accepted as the source's own label CHEMBL2105804 ↗ |
| Known as | Implitapida | ChEMBL registry synonym — accepted as the source's own label CHEMBL2105804 ↗ |
| Modality | Small molecule | — CHEMBL2105804 ↗ |